Clawback: Pharmaceutical Companies in a Deadlock
PhARMA Innovation Forum (PIF) and its 26 biopharmaceutical member companies express their deep concern over the impasse regarding patient access to innovative therapies. According to official data from the National Central Purchasing Body for Health Sector (EKAPY), shared with our companies and covering the first half of 2023, the mandatory clawbacks due to budget overruns…